Synopsis : Halozyme (NASDAQ: HALO) (“Halozyme”) today announced the commercial launch of TLANDO™ (testosterone undecanoate), an oral treatment indicated for testosterone replacement…
Tag:
Halozyme Therapeutics
-
-
Merger / Acquisition
Halozyme has agreed to Acquire Antares Pharma for $960 million.
by adminby adminSummary : Halozyme Therapeutics has announced a formal agreement to acquire all of Antares Pharma’s outstanding shares in a deal worth about…